Introduction
Stent placement has become an increasingly practical and safe procedure with a high technical success rate in patients with vertebral artery origin stenosis (VAOS). However, postoperative restenosis rates vary and controversy exists regarding its application as an optimal treatment. [1] [2] [3] In Japan, with its increasing elderly population, the symptom of ischemia involving the vertebrobasilar artery (VBA) territory is often seen in patients with underlying diseases such as hypertension, diabetes, and renal failure. However, conventional angiography cannot be performed in patients with underlying decreased renal function.
In such patients with renal insufficiency, an alternative is treatment under intravascular ultrasound (IVUS) using little or no contrast medium. Although cost can be an issue, a comparison with conventional endovascular treatment of the iliofemoral artery using contrast medium showed no differences in terms of safety and efficacy, 4 but decreased renal function was reported more often in patients treated with conventional therapy. 5 In the carotid artery territory, carotid artery stenting without contrast medium has been reported, 6 but contrast-less stent placement for VAOS has not been previously described. Moreover, subsequent long-term assessment of restenosis and renal function has not been reported.
We recently performed contrast-less stent placement under IVUS guidance in a patient with chronic kidney disease (CKD) who had deficits in the territory of the posterior communicating arteries bilaterally, unilateral hypoplasia of the vertebral artery (VA), and severegrade VAOS (51-75% stenosis rate) on the dominant side. Treatment has been successful in this patient, with maintenance of renal function and no restenosis over a 2-year follow-up period. We now report the details of this case.
Case report
This 73-year-old man had a sudden onset of dysarthria and mild hemiparesis of the left upper and lower extremities. He was transported and admitted to our hospital with a suspected stroke. His National Institute of Health Stroke Scale (NIHSS) score was 3 upon admission. Cranial magnetic resonance imaging (MRI) showed a fresh lacunar infarction of the right corona radiata. In the intracranial major arteries, only bilateral stenosis of the posterior cerebral arteries was seen. However, in the posterior circulation, the right VA was hypoplastic, and in the dominant left VA, severe stenosis at the origin was suspected (Figure 1(a, b) ).
An infusion of sodium ozagrel was started for the fresh lacunar infarction. By Day 11 after stroke onset, the NIHSS score improved to zero, and the patient was discharged. Blood tests showed decreased renal function with a BUN of 26 mg/dl and a creatinine of 2.0 mg/dl. Therefore, testing and treatment of the left VAOS using contrast medium was not performed at that time. Further testing 3 months after the onset showed no improvement in renal function, thus leading to a diagnosis of CKD. Although symptoms due to lacunar infarction were resolved at that time, asymptomatic VAOS remained a problem. After the patient gave informed consent, percutaneous transluminal angioplasty and stent placement were performed for the treatment of left VAOS under IVUS guidance without the use of contrast medium.
Technical notes
The patient was placed in the supine position on the angiography table, and biplane fluoroscopy was used to ensure an accurate procedure. The right inguinal region was locally anesthetized. Then a 6 F long sheath (SheathLess NV 6 F ST 90 cm; Asahi Intecc, Nagoya, Japan) was inserted through the femoral artery, advanced through the left subclavian artery (SCA), and placed proximally to the VA origin. To stabilize this guiding catheter, a 35-G stiff guidewire (M35/260 cm, RF-PA35263; Terumo Corp, Tokyo, Japan) was positioned in the left brachial artery.
Similarly (Figure 2) . Under ultrasound imaging, the Transend EX guidewire was placed across the stenotic lesion at the left VA origin. The IVUS catheter was advanced along the Transend EX guidewire to the stenotic site, and the size of the stenotic site was assessed (Figure 3(a, b) ).
First, pre-dilatation was performed twice (12 atm, 3.63 mm diameter, 41 s, and 26 s) using an Rx-Genity balloon (3.5-20 mm) (Rx-Genity 3.5 Â 20 mm, RXGT-35020; Kaneka Medix Corp, Osaka, Japan). Next, dilatation was performed (12 atm, 4.64 mm diameter, 42 s) using an Rx-Genity balloon (4.5-20 mm) (Rx-Genity 4.5 Â 20 mm, RXGT-45020). 
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Interventional Neuroradiology 23 (1) Then, the 35-G stiff guidewire in the left SCA was removed, and this was replaced by a 14-G guidewire (Aguru TM Peripheral Guidewire, 0.014 in Â 300 cm, V02-1430S; Boston Scientific, Marlborough, MA). Before stent placement, the IVUS catheter was again advanced through the left SCA to a site where the left VA origin could be visualized. Under IVUS guidance in the left SCA, the position of the proximal edge of the stent at the left VA origin was adjusted.
Finally, an Express Stent (5-15 mm) (Express Vascular SD, 5 mm Â 15 mm, 37917-51515; Boston Scientific) was deployed at 12 atm (Figure 4(a-d) ). Satisfactory dilatation and good blood flow were achieved.
Post-procedural evaluation and follow-up
The patient had a satisfactory post-procedural course without complications such as neurological symptoms or renal failure. Transcutaneous VA ultrasound 3 months later showed less than 25% restenosis at the stent site, and good blood flow was maintained ( Figure 5 ). Transcutaneous VA ultrasound after 13 months postoperatively showed increased restenosis of 26-50% at the stent site, but cranial MRI 19 months later showed no marked changes. Transcutaneous VA ultrasound 26 months later showed that restenosis at the stent site had improved to less than 25%. Clinically, the patient had no neurological symptoms, and renal function did not markedly change.
Discussion
In this elderly patient with CKD and VAOS, satisfactory dilatation was achieved under IVUS guidance without contrast medium. This patient was successfully treated and has had a smooth follow-up course without restenosis or marked changes in renal function now 2 years after the procedure.
Stent placement for VAOS is associated with postprocedural stroke and restenosis. In a systematic review by Stayman et al., the incidence of vertebrobasilar (VB) stroke was 1.2% and VB transient ischemic attacks (TIAs) was 0.9% within 30 days after the procedure. Moreover, after a mean follow-up period of 21 months (range: 1-60 months), VB territory infarction in 1.3% and recurrent VB TIAs in 6.5% of cases were reported. 1 In a review of extracranial vertebral artery stenosis (ECVAS), Kocak et al. reported that although the incidence of complications due to surgery itself, including clinical and technical complications, is low, there are wide differences in long-term restenosis rates. 2 Fortunately, in our patient, post-procedural restenosis as a complication did not occur during short-term or long-term follow-up. However, evidence remains insufficient regarding the safety of stent placement at the VA origin. Patients must therefore be selected with care, and the procedure should only be performed by an experienced surgeon.
The advantage of using contrast medium is the clear imaging of stenotic sites, thus making it easier to determine stent positioning. Transcutaneous ultrasonography is used to evaluate internal carotid artery origin stenosis, but VAOS sites are deeper, and thoracic respiratory motion can make visualization difficult. Moreover, because of blood vessel pulsation with respiration, accurate determination of stent placement is more difficult.
In this regard, IVUS, which provides real-time intravascular visualization of stent dilatation, can be effective, even without the use of contrast medium. IVUS may indeed provide better visualization of the vascular lumen than angiography. IVUS is useful to visualize plaque prolapse from the tines of the stent, particularly after stenting or during angioplasty. 
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Therefore, in patients in whom iodine contrast is contraindicated, including those with decreased renal function, IVUS is an effective alternative for accurate and safe diagnosis and assessment during endovascular repair. 5 In patients with advanced renal disease or allergies to iodinated contrast medium, Ephrem et al. 8 discussed the major advantage of an IVUS approach without the use of fluoroscopy, fluorescent agents, of contrast medium to preserve renal function. In addition, considering the risks of radiation exposure, IVUS is advantageous both for patients and physicians performing these procedures. 8 There is currently insufficient evidence for standardized treatment selection in patients with major arterial stenosis or occlusive lesions involving the VBA system who have decreased renal function. Treatment must be selected after carefully considering each individual patient. However, this case report has significance in that it demonstrates that stent placement under IVUS guidance can be an effective option.
Conclusion
This case report shows that stent placement for VAOS can be safely performed under IVUS guidance in patients in whom contrast medium is contraindicated. This requires sufficient operator experience. IVUS assessment of vessel lumen diameter and status is important in selecting a suitable stent and determining stent placement. 
